wheat bran extract

DIETARY_SUPPLEMENT4 trials

Sponsors

Fugeia NV, Kellogg Company, University of Copenhagen

Conditions

Gastrointestinal HealthHealthyHealthy SubjectsOverweight

Phase 4

Study to Determine the Digestive and Physiological Effects of an Extract From Bran in Healthy Men and Women

CompletedNCT01073969

Kellogg CompanyHealthy

Start: 2009-03-31End: 2009-08-31Updated: 2010-02-23

Unknown Phase

In Vivo Evaluation of the Physiological Effects of Arabinoxylan-oligosaccharides (AXOS) in Healthy Subjects (Adults)

CompletedNCT01002651

Fugeia NVHealthy

Start: 2009-03-31End: 2009-10-31Updated: 2009-10-27

In Vivo Evaluation of the Physiological Effects of Arabinoxylan-oligosaccharides (AXOS) in Healthy Subjects (Juniors)

CompletedNCT01001949

Fugeia NVGastrointestinal Health, Healthy Subjects

Start: 2009-03-31End: 2009-10-31Updated: 2009-10-27

Effect of Prebiotic and PUFA on the Gut Microbiota and Metabolic Risk Markers

CompletedNCT02215343

University of CopenhagenOverweight

Start: 2014-08-31End: 2015-06-30Updated: 2020-05-20

Related Papers

A Multi-omics Approach to Unraveling the Microbiome-Mediated Effects of Arabinoxylan Oligosaccharides in Overweight Humans.

2019-05-2870 citations

Arabinoxylan oligosaccharides and polyunsaturated fatty acid effects on gut microbiota and metabolic markers in overweight individuals with signs of metabolic syndrome: A randomized cross-over trial.

2019-02-1967 citations